Nanjing Chia-Tai Tianqing Pharmaceutical Company, or NJCTTQ for short, was jointly founded by CP Group, a Thai company and Jiangsu Nongken Group. NJCTTQ specializes in research and development, production and commercialization of drugs for cardiovascular diseases, tumors, perioperative care, gastrointestinal disorders and urologic diseases. The company now ranks high among China’s top 100 pharmaceutical companies.